# US 2006/0051393 A1 · Method of manufacturing drug-eluting medical device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0051393 A1
- Document ID: US20060051393A1
- Status: Published application
- Kind: A1
- Application number: 10/936,263
- Filed: 2004-09-08
- Published: 2006-03-09
- Earliest claimed: 2004-09-08
- Assignees: Medtronic, Inc.
- Inventors: Kenneth Heruth; Edouard Koullick; Mark Lent
- Web page: https://patentgrep.com/patent/US20060051393A1

## CPC

- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 29/146: {Porous materials, e.g. foams or sponges}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Methods for manufacturing medical devices comprising a polymeric material capable of releasing a therapeutic agent upon contact with bodily tissue or fluid are described. The method includes generating polymeric material having a matrix into or onto which a therapeutic agent is disposed and having pores. The method further includes disposing additional therapeutic agent into the pores of the polymeric material.

## Claims

### Claim 1

A method for manufacturing a medical device, comprising:
generating a polymeric material comprising therapeutic agent and pores; and
disposing additional therapeutic agent in the pores,
wherein at least a portion of a structural surface layer of the device comprises the polymeric material comprising therapeutic agent and pores,
wherein the therapeutic agent and the additional therapeutic agent are the same or different.

### Claim 2 (depends on 1)

The method of claim 1, wherein the generating the polymeric material comprises:
blending an uncured or unset polymer with the therapeutic agent and a porogen to produce a mixture;
curing or setting the mixture; and
removing the porogen to generate the polymeric material comprising therapeutic agent and pores.

### Claim 3 (depends on 1)

The method of claim 1, wherein the generating the polymeric material comprises:
blending an uncured or unset polymer with a porogen to produce a mixture;
curing or setting the mixture to produce a material comprising pores;
impregnating the material comprising pores with the therapeutic agent to generate the polymeric material comprising therapeutic agent and pores.

### Claim 4 (depends on 3)

The method of claim 3, wherein the impregnating the material comprising pores with therapeutic agent comprises:
swelling the material comprising pores; and
introducing therapeutic agent into the swelled material via a solvent vehicle.

### Claim 5 (depends on 1)

The method of claim 1, wherein the generating the polymeric material comprises:
mixing an uncured or unset polymer with a gas;
curing or setting the polymer and removing the gas to generate a material comprising pores;
impregnating the material comprising pores with the therapeutic agent to generate the polymeric material comprising therapeutic agent and pores.

### Claim 6 (depends on 5)

The method of claim 5, wherein the impregnating the material comprising pores with therapeutic agent comprises:
swelling the material comprising pores; and
introducing therapeutic agent into the swelled material via a solvent vehicle.

### Claim 7 (depends on 5)

The method of claim 5, wherein the mixing the uncured or unset polymer with a gas comprises foaming the uncured or unset polymer.

### Claim 8 (depends on 1)

The method of claim 1, wherein the generating the polymeric material comprises:
mixing an uncured or unset polymer with a gas and the therapeutic agent;
curing or setting the polymer and removing the gas to generate the polymeric material comprising therapeutic agent and pores.

### Claim 9 (depends on 5)

The method of claim 5, wherein the mixing the uncured or unset polymer with a gas comprises foaming the uncured or unset polymer.

### Claim 10 (depends on 1)

The method of claim 1, wherein the disposing additional therapeutic agent in the pores comprises:
contacting the polymeric material comprising therapeutic agent and pores with a solution or mixture comprising the additional therapeutic agent and a solvent; and
removing the solvent to deposit additional therapeutic agent in the pores.

### Claim 11 (depends on 10)

The method of claim 10, wherein the contacting the polymeric material with the solution or mixture swells the polymeric material.

### Claim 12 (depends on 11)

The method of claim 11, wherein at least a portion of the additional therapeutic agent impregnates the polymeric material.

### Claim 13 (depends on 10)

The method of claim 10, wherein contacting the polymeric material with the solution of mixture does not substantially swell the polymeric material.

### Claim 14 (depends on 1)

The method of claim 1, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising pores and a therapeutic agent selected from the group consisting of one or more anti-infective agent, one or more anti-inflammatory agent, one or more local anesthetic, one or more anti-proliferative agent, and a combination thereof.

### Claim 15 (depends on 14)

The method of claim 14, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising one or more anti-infective agent and one or more anti-inflammatory agent.

### Claim 16 (depends on 14)

The method of claim 14, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising one or more anti-inflammatory agent and one or more anti-proliferative agent.

### Claim 17 (depends on 14)

The method of claim 14, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising minocycline, rifampin, chlorhexidine, clindamycin, a silver-containing compound, or combinations thereof.

### Claim 18 (depends on 17)

The method of claim 17, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising minocycline and rifampin.

### Claim 19 (depends on 17)

The method of claim 17, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising chlorhexidine and silver sulfadiazine.

### Claim 20 (depends on 17)

The method of claim 17, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising clindamycin and rifampin.

### Claim 21 (depends on 1)

The method of claim 1, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores an agent selected from the group consisting of one or more anti-infective agent, one or more anti-inflammatory agent, one or more local anesthetic, one or more anti-proliferative agent, and combinations thereof.

### Claim 22 (depends on 21)

The method of claim 21, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores one or more anti-infective agent and one or more anti-inflammatory agent.

### Claim 23 (depends on 21)

The method of claim 21, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores one or more anti-inflammatory agent and one or more anti-proliferative agent.

### Claim 24 (depends on 21)

The method of claim 21, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores minocycline, rifampin, chlorhexidine, clindamycin, a silver-containing compound, or combinations thereof.

### Claim 25 (depends on 24)

The method of claim 24, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores minocycline and rifampin.

### Claim 26 (depends on 24)

The method of claim 24, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores chlorhexidine and silver sulfadiazine.

### Claim 27 (depends on 24)

The method of claim 24, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores clindamycin and rifampin.

### Claim 28 (depends on 1)

The method of claim 1, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising silicone.

### Claim 29 (depends on 28)

The method of claim 28, wherein the silicon is silicone RTV.

### Claim 30 (depends on 1)

The method of claim 1, wherein the generating a polymeric material comprising therapeutic agent and pores comprises:
generating a polymeric material comprising polyurethane.

### Claim 31

A method for manufacturing a medical device, comprising:
disposing therapeutic agent into or on a polymeric material;
creating pores in the polymeric material, disposing the polymeric material on or about a surface layer of the device; and
disposing additional therapeutic agent in the pores.

### Claim 32 (depends on 31)

The method of claim 31, wherein the disposing the polymeric material on or about a at least a portion of a surface layer of the device comprises disposing a polymeric material comprising therapeutic agent and pores and additional therapeutic agent disposed in the pores on or about the device.

### Claim 33 (depends on 31)

The method of claim 31, wherein disposing the additional therapeutic agent in the pores comprises disposing additional therapeutic agent in the pores of a polymeric material disposed on or about at least a portion of a surface layer of the device, the polymeric material comprising therapeutic agent and the pores.

### Claim 34 (depends on 31)

The method of claim 31, further comprising disposing one or more intermediate layer on at least a portion of the surface layer of the device and disposing the polymeric material one of the one or more intermediate layers.

### Claim 35 (depends on 31)

The method of claim 31, wherein the surface layer comprises metallic material.

### Claim 36 (depends on 31)

The method of claim 31, wherein the surface layer comprises a polymer.

### Claim 37 (depends on 31)

The method of claim 31, wherein the disposing therapeutic agent into or on a polymeric material comprises:
blending an uncured or unset polymer with the therapeutic agent to produce a mixture; and
curing or setting the mixture.

### Claim 38 (depends on 31)

The method of claim 31, wherein the disposing therapeutic agent into or on a polymeric material comprises:
impregnating the polymeric material with the therapeutic agent.

### Claim 39 (depends on 38)

The method of claim 38, wherein the impregnating the polymeric material with the therapeutic agent comprises:
swelling the polymeric material; and
introducing therapeutic agent into the swelled polymeric material via a solvent vehicle.

### Claim 40 (depends on 31)

The method of claim 31, wherein the creating pores in the polymeric material comprises:
blending an uncured or unset polymeric material with a porogen;
curing or setting the polymeric material; and
removing the porogen to create pores in the polymeric material.

### Claim 41 (depends on 31)

The method of claim 31, wherein the creating pores in the polymeric material comprises:
mixing an uncured or unset polymeric material with a gas;
curing or setting the polymeric and removing the gas to generate a polymeric material comprising pores.

### Claim 42 (depends on 41)

The method of claim 41, wherein the mixing an uncured or unset polymeric material with a gas comprises foaming the uncured or unset polymeric material.

### Claim 43 (depends on 31)

The method of claim 31, wherein the disposing additional therapeutic agent in the pores comprises:
contacting polymeric material comprising pores with a solution or mixture comprising the additional therapeutic agent and a solvent; and
removing the solvent to deposit additional therapeutic agent in the pores.

### Claim 44 (depends on 43)

The method of claim 43, wherein the contacting the polymeric material with the solution or mixture swells the polymeric material.

### Claim 45 (depends on 44)

The method of claim 44, wherein at least a portion of the additional therapeutic agent impregnates the polymeric material.

### Claim 46 (depends on 43)

The method of claim 43, wherein contacting the polymeric material with the solution of mixture does not substantially swell the polymeric material.

### Claim 47 (depends on 31)

The method of claim 31, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material a therapeutic agent selected from the group consisting of one or more anti-infective agent, one or more anti-inflammatory agent, one or more local anesthetic, one or more anti-proliferative agent, and combinations thereof.

### Claim 48 (depends on 47)

The method of claim 47, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material one or more anti-infective agent and one or more anti-inflammatory agent.

### Claim 49 (depends on 47)

The method of claim 47, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material one or more anti-inflammatory agent and one or more anti-proliferative agent.

### Claim 50 (depends on 47)

The method of claim 47, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material minocycline, rifampin, chlorhexidine, clindamycin, a silver-containing compound, or combinations thereof.

### Claim 51 (depends on 50)

The method of claim 50, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material minocycline and rifampin.

### Claim 52 (depends on 50)

The method of claim 50, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material chlorhexidine and silver sulfadiazine.

### Claim 53 (depends on 50)

The method of claim 50, wherein the disposing therapeutic agent into or on a polymeric material comprises:
disposing into or on the polymeric material clindamycin and rifampin.

### Claim 54 (depends on 31)

The method of claim 31, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores an agent selected from the group consisting of one or more anti-infective agent, one or more anti-inflammatory agent, one or more local anesthetic, one or more anti-proliferative agent, and a combination thereof.

### Claim 55 (depends on 54)

The method of claim 54, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores one or more anti-infective agent and one or more anti-inflammatory agent.

### Claim 56 (depends on 54)

The method of claim 54, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores one or more anti-inflammatory agent and one or more anti-proliferative agent.

### Claim 57 (depends on 54)

The method of claim 54, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores minocycline, rifampin, chlorhexidine, clindamycin, a silver-containing compound, or combinations thereof.

### Claim 58 (depends on 57)

The method of claim 57, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores minocycline and rifampin.

### Claim 59 (depends on 57)

The method of claim 57, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores chlorhexidine and silver sulfadiazine.

### Claim 60 (depends on 57)

The method of claim 57, wherein the disposing additional therapeutic agent in the pores comprises:
disposing in the pores clindamycin and rifampin.

### Claim 61 (depends on 31)

The method of claim 31, wherein the polymeric material comprises silicone.

### Claim 62 (depends on 61)

The method of claim 61, wherein the silicon is silicone RTV.

### Claim 63 (depends on 31)

The method of claim 31, wherein the polymeric material comprises polyurethane.
